December 21, 2014 11:32 PM ET

Biotechnology

Company Overview of Protea Biosciences Group, Inc

Company Overview

Protea Biosciences Group, Inc., a molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. The company offers laser ablation electrospray ionization (LASEI), a bioanalytical instrument platform that enables the identification of proteins, lipids, and metabolites in tissue, cells, and biofluids, such as serum and urine without any sample preparation prior to analysis. It also provides bioanalytical consumable products for use in bioanalytical mass spectrometry, including Progenta surfactants that remove proteins out of biological samples and into ...

955 Hartman Run Road

Morgantown, WV 26507

United States

Founded in 2001

47 Employees

Phone:

304-292-2226

Fax:

304-292-7101

Key Executives for Protea Biosciences Group, Inc

Chairman
Age: 68
Total Annual Compensation: $240.0K
Chief Financial Officer
Age: 60
Total Annual Compensation: $145.6K
Chief Science Officer and Director of Research & Development
Age: 39
Total Annual Compensation: $146.2K
Vice President and General Manager
Age: 57
Total Annual Compensation: $240.0K
Compensation as of Fiscal Year 2013.

Protea Biosciences Group, Inc Key Developments

Protea Biosciences Group, Inc Presents at LD Micro Conference, Dec-04-2014 01:00 PM

Protea Biosciences Group, Inc Presents at LD Micro Conference, Dec-04-2014 01:00 PM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States. Speakers: Stephen C. Turner, Chairman, Chief Executive Officer and President.

Protea Biosciences Group, Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Protea Biosciences Group Inc. announced earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported gross revenue totaled $517,569, a 190% increase compared to the third quarter of 2013 and the high revenue for any quarter in the company's history. Net loss was $4,658,776 compared to $2,554,923 for the same period in 2013. For the nine months, the company reported gross revenue totaled $1,332,230, compared to $938,080 for the same period of 2013, representing a 42% increase. The company's two core lines of business, molecular information services and LAESI instrument platforms, showed greater than 200% increases in gross revenues for the third quarter period over the same period in 2013. Net loss totaled $10,837,252 compared to $7,916,882 for the same period of 2013, which includes a non-cash charge of $2.08 million in fair market value on derivatives related to anti-dilution protection on certain securities.

Protea Biosciences Group, Inc Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-11-2014 02:00 PM

Protea Biosciences Group, Inc Presents at Aegis Capital 2014 Healthcare & Technology Conference, Sep-11-2014 02:00 PM. Venue: The Encore at Wynn Las Vegas, 3121 Las Vegas Blvd. South, Las Vegas, NV 89109, United States.

Similar Private Companies By Industry

Company Name Region
University Genomics, Inc. United States
SerOptix, Inc. United States
Chrono Therapeutics Inc. United States
Tetracore, Inc. United States
PhycoBiologics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 31, 2014
--
Private Placement
April 2, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Protea Biosciences Group, Inc, please visit www.proteabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.